Skip to content
Companies

Lab Angelus

Tracking cancer specimens from pathology labs to test labs

Raised to date

$350K

of $1M offered across 1 Form D filing

Still open
$650K
Investors
1
Last filed
Aug 14, 2026

About

Lab Angelus is a Kansas City-area healthcare technology company building the coordination layer for precision oncology. Its platform connects community pathology practices, molecular reference laboratories, and treating oncologists so cancer specimens and molecular test results move through one traceable digital workflow instead of faxes, phone calls, and separate lab portals. Its flagship product, LabDispatch, is in commercial deployment with a publicly traded molecular diagnostics partner and is distributed through the Independent Pathology Practice Network.

Compliance-first architecture — Anti-Kickback Statute Personal Services Safe Harbor, HIPAA, and SOC 2 designed in from the first line of code — combined with existing relationships into the Independent Pathology Practice Network and the academic GOAL consortium, giving it access to both the source and destination labs it connects.

Funding

  • Security to be acquiredFiled Aug 14, 2026Form D
    $350K/ $1M

Product

LabDispatch

Healthcare workflow platform

A digital coordination and specimen-logistics platform that connects community pathology laboratories to the national molecular reference laboratories performing genomic cancer testing, tracking each request from draft through dispatch, transit, receipt, and result.

  • End-to-end request tracking: drafts, requested, dispatched, in-transit, received, resulted, returned, archived
  • HL7 FHIR resources for orders, specimens, and reports
  • Integrations with the EHR and laboratory information systems community practices already run

Built for

Community pathology practices and the molecular reference laboratories they send cancer specimens to, plus the treating oncologists receiving results

People on file